CodeMap® 

150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2021
2020 (July)

Physician Fee Schedule

2021
2020

OPPS Fee Schedule

2021-April
2021-January

ASC Fee Schedule

2021-April
2021-January

APC Codes

2021-April
2021-January

DRG Codes

2021
2020

ASP Drug Pricing Files

April 2021
January 2021


CMS Transmittals




Next Webinar 05/19/2021:
How to Structure Financial Arrangements with Customers

CodeMap® LCD-L38121

 

Printer Friendly Version

L38121
LCD for MolDX: Next-Generation Sequencing for Solid Tumors (L38121)
See related Articles:
A57905-Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
A57906-Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors

Contractor Information

Contractor Name: Noridian Healthcare Solutions, LLC - Full list of policies of this Medicare Contractor

Contractor Number: 02401

Contractor Type: MAC A

LCD Information

LCD ID Number: L38121 Status: A-Approved

LCD Title: MolDX: Next-Generation Sequencing for Solid Tumors

Geographic Jurisdiction: Washington Other Jurisdictions

Original Determination Effective Date: 05/17/2020

Original Determination Ending Date:

Revision Effective Date:

Revision End Date:

CMS National Coverage Policy:

Title XVIII of the Social Security Act (SSA), §1862(a)(1)(A), states that no Medicare payment shall be made for items or services that “are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.”

42 Code of Federal Regulations (CFR) §410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions.

CMS On-Line Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, §§80.0, 80.1.1, 80.2. Clinical Laboratory services.

CMS Internet-Only Manual, Pub 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 2, §90.2 Next-Generation Sequencing (NGS) for Patients with Advanced Cancer.


Sorry, you need to login or register to view additional sections of this Medicare policy.

--
*
All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

05/10/2021 10:15:48 3.226.72.118


CodeMap® is a Registered Trademark of Wheaton Partners, LLC.